Patent · US Expired

Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide

US5723125A · kind A · utility

166Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 25, 1996
Grant dateMar 3, 1998
Priority date
Expiry dateSep 25, 2016

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a hybrid recombinant protein consisting of human interferon, preferably interferon-.alpha. (IFN.alpha.), and human immunoglobulin Fc fragment, preferably .gamma.4 chain, joined by a peptide linker comprising the sequence Gly Gly Ser Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser (SEQ ID NO:1).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.